`
`Corporate Information
`
`Financial Information
`
`Careers
`
`Contact Us
`
`Our Generic Drug Division
`
`Our Proprietary Products Division
`
`Par Pharmaceutical, our generic
`drug division, is committed to
`providing high-quality
`pharmaceuticals that are affordable
`and accessible to patients.
`
`Strativa Pharmaceuticals, our
`proprietary products division, is
`committed to finding, enhancing and
`bringing to market drugs that make
`a meaningful difference to patients.
`
`Par Sterile Products, LLC is
`committed to providing high quality
`sterile injectable products that are
`affordable and accessible to
`patients.
`
`Par Laboratories Europe, Ltd. is
`committed to providing high-quality
`pharmaceuticals that are affordable
`and accessible to patients.
`
`11/12/14 – Par Pharmaceutical Announces First FDA Approval of Vasostrict™ (vasopressin injection, USP)
`
`© 2010 Par Pharmaceutical Companies, Inc.
`
`Sitemap | Terms of Use | Privacy Policy | Compliance | Public Re
`
`http://www.parpharm.com/
`
`1/1
`
`JAZZ EXHIBIT 2019
`Amneal Pharms. et al. (Petitioners) v. Jazz Pharms., Inc. (Patent Owner)
`Case IPR2015-00554
`
`Page 1 of 1